ATYR Competitors & Alternatives

Compare aTyr Pharma, Inc. with similar stocks in the same industry

Biotechnology

ATYR

Main Stock
$4.96
-5.34%
Tradestie Score
33
Market Cap
$67.65M
Analyst Upside
+810.6%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: tRNA synthetase modulators, immunomodulatory protein therapeutics
Major Customers 2
clinical research organizations academic collaborators
Critical Suppliers 2
CROs CMOs for biologics manufacturing
Direct Ecosystem Rivals 2

Top Competitors

219 stocks in Biotechnology
Company Price Market Cap P/E Score Action
NVCT Nuvectis Pharma, Inc. Common Stock
$19.18
+0.37%
$154.27M - 54 Compare
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$7.07
-0.70%
$137.59M - 37 Compare
CLYM Climb Bio, Inc. Common Stock
$9.63
-3.12%
$133.50M - 45 Compare
CGTX Cognition Therapeutics, Inc. Common Stock
$0.63
-1.44%
$133.22M - 55 Compare
SRZN Surrozen, Inc. Common
$30.16
-6.68%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$25.11
-7.41%
$110.20M - 34 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.03
+0.17%
$84.52M - 53 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.20
-3.74%
$67.94M - 52 Compare
IXHL Incannex Healthcare Limited American Depositary Shares
$1.73
-10.36%
$40.49M - 52 Compare
ATCH AtlasClear Holdings, Inc.
$0.08
-37.17%
$7.15M 6.6 41 Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2836)

219 stocks in this industry